| Model Number |
MODEL 3100 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Wound Dehiscence (1154); Pocket Erosion (2013); Unspecified Heart Problem (4454)
|
| Date of Event |
08/21/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
The battery (b)(6) was returned to ebr for analysis and received on 22 august 2025.However, the investigation is in process.Ebr submits this report to comply with fda regulations 21 cfr parts 4 and 803.Ebr has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by the fda, ebr or its employee, that the device, ebr or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Ebr will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient experienced wound dehiscence with battery erosion through the skin.A decision regarding battery replacement will be made following wound healing.No additional information has been received.
|
| |
|
Additional Manufacturer Narrative
|
|
Both the battery (s/n (b)(6)) and the transmitter (t02419) were returned to ebr for evaluation.Returned product evaluation revealed no physical damage, contamination, or anomalies that could have contributed to the reported condition.Functional testing was not warranted as no performance issues were reported, and both devices met all manufacturing and release specifications.Lot history review (battery lot p240165; transmitter lot p250032) confirmed no manufacturing nonconformances, deviations, or sterility issues.The event is consistent with known procedural and patient-specific complications identified in the wise crt instructions for use, including wound healing issues and skin erosion overlying the implant site.The devices met specification with no evidence of malfunction or manufacturing defect.The event is attributed to patient and surgical factors, not a device failure.Device erosion and wound dehisence are known medical risks when the skin barrier is breached.Analysis of the returned product is not able to provide relevant information for skin erosion or wound dehiscence related allegations.
|
| |
|
Additional Manufacturer Narrative
|
|
The initial mdr (3013596742-2025-00016) in section h11 incorrectly stated that battery (b)(6) was associated with this complaint.The correct devices associated with complaint (b)(4) are battery (b)(6) and transmitter (b)(6).These devices have not been returned to the manufacturer for analysis; however, follow-up efforts have been made to obtain product return status.A lot history record (lhr) review for both the battery (b)(6) and transmitter (b)(6) was performed.The review identified no process-related non-conformances, scrap, or rework during production that would explain the reported event.The reported patient symptoms of device erosion and wound dehiscence are recognized as potential adverse events or complications associated with the wise crt system, as described in the instructions for use (ifu).
|
| |
|
Search Alerts/Recalls
|